Cannabis Incannex receives positive feedback from FDA for its brain injury treatment drug The company says the FDA is very interested in developing IHL-216A for the treatment of TBI Rowan DunneOctober 11, 2022
Cannabis Incannex partners with Curia to accelerate production of IHL-216A New inhalable drug containing CBD designed for efficacious treatment of brain injuries Rowan DunneAugust 2, 2022